PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC

NCT06062602 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: TAK-676
DRUG: Carboplatin
DRUG: 5-FU
DRUG: Paclitaxel
COMBINATION_PRODUCT: TAK-676 + Carboplatin
COMBINATION_PRODUCT: Carboplatin + Paclitaxel
COMBINATION_PRODUCT: Carboplatin + 5-FU
COMBINATION_PRODUCT: TAK-676 + Carboplatin + 5-FU
COMBINATION_PRODUCT: TAK-676 + Carboplatin + Paclitaxel

Sponsor

Presage Biosciences

Collaborators

[object Object]